Literature DB >> 6650765

Management of the newborn with gastrointestinal anomalies and tracheoesophageal fistula.

D L Mollitt, E S Golladay.   

Abstract

A standard approach to the otherwise healthy newborn with esophageal atresia and tracheoesophageal fistula has been well established. A significant number of these infants have additional gastrointestinal anomalies that necessitate alteration of the usual operative management. Over 2 1/2 years, nine such newborns have been managed. There were 17 additional gastrointestinal abnormalities, the most frequent being an imperforate anus (5), malrotation (5), and intestinal atresia (4). Management consisted of initial formal laparotomy, thoracotomy, and central line placement. In four infants these procedures were performed at a single sitting. Eight infants survived (89 percent); the single death resulted from intracerebral hemorrhage. Detection of coexisting gastrointestinal anomalies is mandatory in the management of the newborn with esophageal atresia. Standard local gastrostomy and subsequent thoracotomy may delay recognition of these associated anomalies, increase morbidity, and complicate subsequent correction. Preliminary abdominal exploration with correction, diversion, or both followed by thoracotomy, either immediate or staged, is indicated.

Entities:  

Mesh:

Year:  1983        PMID: 6650765     DOI: 10.1016/0002-9610(83)90343-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Tracheo-oesophageal fistula with agenesis of right lung.

Authors:  M J Ambroise; A J Veliath; P Nalini
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

2.  The management of combined oesophageal and duodenal atresia.

Authors:  S Dave; E C P Shi
Journal:  Pediatr Surg Int       Date:  2004-09-11       Impact factor: 1.827

3.  Magnetic compression stricturoplasty in patients with severe stricture after simultaneous esophageal atresia and duodenal obstruction repair: A case report.

Authors:  Shiqi Liu; Ying Fang; Yi Lv; Jingru Zhao; Ruixue Luo; Ruogu Luo; Jun Cheng; Hongbin Yang; Anpeng Zhang; Yingchun Shen; Na Jiang
Journal:  Exp Ther Med       Date:  2021-11-30       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.